141 related articles for article (PubMed ID: 8654200)
1. Liver volume as a determinant of drug clearance in children and adolescents.
Murry DJ; Crom WR; Reddick WE; Bhargava R; Evans WE
Drug Metab Dispos; 1995 Oct; 23(10):1110-6. PubMed ID: 8654200
[TBL] [Abstract][Full Text] [Related]
2. Hepatic drug clearance in patients with mild cystic fibrosis.
Kearns GL; Crom WR; Karlson KH; Mallory GB; Evans WE
Clin Pharmacol Ther; 1996 May; 59(5):529-40. PubMed ID: 8646824
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine.
Crom WR; Relling MV; Christensen ML; Rivera GK; Evans WE
Clin Pharmacol Ther; 1991 Aug; 50(2):132-40. PubMed ID: 1868674
[TBL] [Abstract][Full Text] [Related]
4. Enhanced hepatic drug clearance in patients with cystic fibrosis.
Kearns GL; Mallory GB; Crom WR; Evans WE
J Pediatr; 1990 Dec; 117(6):972-9. PubMed ID: 2246703
[TBL] [Abstract][Full Text] [Related]
5. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
Figg WD; Dukes GE; Lesesne HR; Carson SW; Songer SS; Pritchard JF; Hermann DJ; Powell JR; Hak LJ
Pharmacotherapy; 1995; 15(6):693-700. PubMed ID: 8602375
[TBL] [Abstract][Full Text] [Related]
6. Effect of neurotrauma on hepatic drug clearance.
Boucher BA; Kuhl DA; Fabian TC; Robertson JT
Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):487-97. PubMed ID: 1934861
[TBL] [Abstract][Full Text] [Related]
7. Modifications of blood volume alter the disposition of markers of blood volume, extracellular fluid, and total body water.
Krejcie TC; Henthorn TK; Gentry WB; Niemann CU; Enders-Klein C; Shanks CA; Avram MJ
J Pharmacol Exp Ther; 1999 Dec; 291(3):1308-16. PubMed ID: 10565856
[TBL] [Abstract][Full Text] [Related]
8. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
Hashimoto M; Watanabe G
J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
[TBL] [Abstract][Full Text] [Related]
9. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
Relling MV; Crom WR; Pieper JA; Cupit GC; Rivera GK; Evans WE
Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
[TBL] [Abstract][Full Text] [Related]
10. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage.
Linday LA; Greenblatt DJ; Warren MP; Harmatz JS; DeCresce R; Cicalese C; LeDuc BW
Dev Pharmacol Ther; 1991; 16(4):194-202. PubMed ID: 1782837
[TBL] [Abstract][Full Text] [Related]
11. Liver volume, portal vein flow, and clearance of indocyanine green and antipyrine in hyperthyroidism before and after antithyroid treatment.
Andersen V; Sonne J; Court-Payen M; Sletting S; Prip A; Mølholm Hansen J
Scand J Gastroenterol; 1999 Jun; 34(6):618-22. PubMed ID: 10440613
[TBL] [Abstract][Full Text] [Related]
12. Indexing glomerular filtration rate to suit children.
Bird NJ; Henderson BL; Lui D; Ballinger JR; Peters AM
J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
[TBL] [Abstract][Full Text] [Related]
13. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
Andersen V; Sonne J; Larsen S
Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483
[TBL] [Abstract][Full Text] [Related]
14. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig.
Monshouwer M; Witkamp RF; Nijmeijer SM; Pijpers A; Verheijden JH; Van Miert AS
Xenobiotica; 1995 May; 25(5):491-9. PubMed ID: 7571722
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
van Bezooijen CF; van Oorschot RM
J Pharmacol Exp Ther; 1989 Nov; 251(2):683-6. PubMed ID: 2810117
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
[TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
[TBL] [Abstract][Full Text] [Related]
18. Human cytochrome P450 maximal activities in pediatric versus adult liver.
Blanco JG; Harrison PL; Evans WE; Relling MV
Drug Metab Dispos; 2000 Apr; 28(4):379-82. PubMed ID: 10725303
[TBL] [Abstract][Full Text] [Related]
19. Effect of experimental hemorrhagic shock on hepatic drug elimination.
DiPiro JT; Hooker KD; Sherman JC; Gaines MG; Wynn JJ
Crit Care Med; 1992 Jun; 20(6):810-5. PubMed ID: 1597036
[TBL] [Abstract][Full Text] [Related]
20. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
